Schering-Plough Announces Strategy and Action Plan on Social Issues
Schering-Plough Corporation launches a long-term plan to identify and address broad societal issues as part of the company's strategic business process.
"By the nature of our business, social issues are integral to the pharmaceutical industry," said Chairman and CEO Fred Hassan. "Our industry has a special responsibility because drugs are essential to prolonging and improving the quality of life. Our new plan will enable us to identify pressing social issues, respond appropriately and maximize the impact of the resources we can bring to bear."
Current priorities to be addressed under Schering-Plough's plan (not in rank order) are: patient safety; access to medicines for patients who are indigent, disadvantaged or among the working poor; ethical practices in sales, marketing, clinical research, and supplier management; human rights, including living wage, health benefits for workers and no child labor; security, occupational health and safety, and the environment; diversity, both at the Board of Directors level and in the workforce; and corporate governance.
The plan will be integrated with the company's business planning and implementation processes. The plan will be aligned with the company's overall strategies for driving long-term growth and stewardship of shareholder investments.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
BASF moves forward in acquisition of Solvay's polyamide business - BASF offered commitments to meet concerns of the EU Commission
Merck announces outcome of IIIb study for Kuvan
Noble way to low-cost fuel cells, halogenated graphene may replace expensive platinum
Nano-velcro clasps heavy metal molecules in its grips - Researchers develop nano-strips for inexpensive testing of mercury levels in our lakes and oceans with unprecedented sensitivity
Controlling phase changes in solids - A recent study demonstrates the rapid control of phase-changes in resonantly bonded materials
Category:American_pharmacologists
